PRECIPIO, INC. Other Significant Noncash Transaction, Value of Consideration Given
PRECIPIO, INC. (PRPO) reported Other Significant Noncash Transaction, Value of Consideration Given of $460.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 · last filed 2020-03-27
- PRECIPIO, INC. other significant noncash transaction, value of consideration given for the quarter ending 2019-12-31 was $0.00.
- PRECIPIO, INC. other significant noncash transaction, value of consideration given for the quarter ending 2019-09-30 was $0.00.
- PRECIPIO, INC. other significant noncash transaction, value of consideration given for the quarter ending 2019-06-30 was $0.00.
- PRECIPIO, INC. other significant noncash transaction, value of consideration given for the quarter ending 2019-03-31 was $460.00K.
- PRECIPIO, INC. other significant noncash transaction, value of consideration given for fiscal 2019 was $460.00K, a 0.00% change from fiscal 2018.
- PRECIPIO, INC. other significant noncash transaction, value of consideration given for fiscal 2018 was $460.00K.
| Period end | Other Significant Noncash Transaction, Value of Consideration Given 3 month | Other Significant Noncash Transaction, Value of Consideration Given 6 month | Other Significant Noncash Transaction, Value of Consideration Given 9 month | Other Significant Noncash Transaction, Value of Consideration Given 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $0.00 derived: sum of 2 quarters · filed 2020-03-27 | $0.00 derived: sum of 3 quarters · filed 2020-03-27 | $460.00K 10-K · filed 2020-03-27 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $460.00K 10-Q · filed 2019-11-13 | $460.00K derived: sum of 4 quarters · filed 2020-03-27 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $460.00K 10-Q · filed 2019-08-09 | $460.00K derived: sum of 3 quarters · filed 2020-03-27 | $460.00K derived: sum of 4 quarters · filed 2020-03-27 |
| 2019-03-31 | $460.00K 10-Q · filed 2019-05-16 | $460.00K derived: sum of 2 quarters · filed 2020-03-27 | $460.00K derived: sum of 3 quarters · filed 2020-03-27 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $0.00 derived: sum of 2 quarters · filed 2020-03-27 | $460.00K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $460.00K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $460.00K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |